Samuel Kintz - Insider Trading & Ownership

Entity
Individual
Location
Enliven Therapeutics Inc, 6200 Lookout Road, Boulder, Colorado
Summary
The estimated net worth of Samuel Kintz is at least $29.2M dollars as of August 2, 2024. Samuel Kintz is the PRESIDENT AND CEO, Director of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $29.2M.
All Insider Reports
All Insider Reports

Ownership of Samuel Kintz

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ELVN Enliven Therapeutics, Inc. PRESIDENT AND CEO, Director $29.2M -$3.55M -10.8% Jul 31, 2024

Insider Transactions Reported by Samuel Kintz:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership